FDA Outlines Next Steps In Regulatory Science
This article was originally published in The Gray Sheet
FDA plans to invest in eight priority areas for regulatory science, including better tools for reviewing innovative technologies and new manufacturing approaches, according to a strategic plan released Aug. 17.
You may also be interested in...
FDA's Science Board will create a new subcommittee to provide guidance on regulatory science needs in a “rapidly changing future,” according to FDA Chief Scientist Jesse Goodman.
FDA plans to publicly issue its staff manual on scientific integrity in the near future.
510(k) modifications guidance